The China hemodialysis and peritoneal dialysis market has experienced significant growth, reaching a valuation of USD 7.18 billion in 2024. This growth is largely driven by the increasing incidence of end-stage renal disease (ESRD) in the country. As the prevalence of chronic kidney diseases rises, the demand for dialysis treatments has surged. With improvements in healthcare infrastructure and technological advancements in dialysis equipment, more patients in China are gaining access to life-saving treatments. The market is set to continue its expansion, with significant investments in both hemodialysis and peritoneal dialysis treatments, catering to the growing patient base.

China Hemodialysis and Peritoneal Dialysis Market Size

In 2024, the China hemodialysis and peritoneal dialysis market was valued at USD 7.18 billion. The market is expected to grow at a compound annual growth rate (CAGR) of 9.30% during the forecast period from 2025 to 2034. By 2034, the market is anticipated to reach a value of USD 17.47 billion. This substantial growth is driven by an aging population, an increase in chronic diseases, and an enhanced focus on improving healthcare access for dialysis patients. With more advanced treatment options becoming available, the market's expansion is inevitable.

China Hemodialysis and Peritoneal Dialysis Market Trends

Several trends are currently shaping the hemodialysis and peritoneal dialysis market in China:

• Rising Incidence of Chronic Kidney Disease: The growing prevalence of diabetes, hypertension, and other lifestyle-related diseases in China has led to an increased number of kidney failure cases, which, in turn, drives the demand for dialysis.

• Technological Advancements: Continuous innovation in dialysis equipment, such as portable dialysis machines, automated peritoneal dialysis systems, and improved dialyzers, is enhancing the quality and accessibility of dialysis treatments.

• Improved Healthcare Infrastructure: China's healthcare system is expanding its capabilities, with more hospitals and dialysis centers offering advanced treatment options. This expansion increases accessibility for patients, particularly those in rural areas.

• Home Dialysis Options: With an increasing focus on patient comfort and convenience, home dialysis treatments, including home hemodialysis and peritoneal dialysis, are gaining popularity in China. These options provide more autonomy and flexibility for patients.

China Hemodialysis and Peritoneal Dialysis Market Growth

The market for hemodialysis and peritoneal dialysis in China is on a strong growth trajectory, fueled by various factors:

• Increasing Prevalence of End-Stage Renal Disease (ESRD): The growing number of people diagnosed with ESRD is the primary driver behind the demand for dialysis treatments. As chronic kidney disease (CKD) progresses to ESRD, dialysis becomes a critical treatment option for many patients.

• Government Support and Healthcare Initiatives: The Chinese government has been investing heavily in healthcare improvements, including the provision of dialysis treatments for patients across the country. Increased funding and healthcare policies designed to support dialysis care are contributing to the market's growth.

• Healthcare Infrastructure Development: With better healthcare facilities and more widespread dialysis centers, patients have greater access to dialysis treatments, which supports market growth. This infrastructure expansion, particularly in rural areas, is a key factor in the rising adoption of dialysis therapies.

• Rising Awareness and Early Diagnosis: Increased awareness about kidney disease, along with improved diagnostic tools, has led to more patients being diagnosed at earlier stages. This proactive approach to treatment helps prevent the progression of kidney disease and reduces the burden on dialysis centers.

China Hemodialysis and Peritoneal Dialysis Market Segmentation

China Hemodialysis and Peritoneal Dialysis Market Forecast

The hemodialysis and peritoneal dialysis market in China is projected to experience substantial growth in the coming years. The market, valued at USD 7.18 billion in 2024, is expected to grow at a robust CAGR of 9.30% from 2025 to 2034. By 2034, the market is expected to reach USD 17.47 billion, driven by the increased prevalence of ESRD, advancements in dialysis technologies, and government healthcare initiatives. The increasing adoption of home dialysis systems, technological innovations, and expanding healthcare infrastructure are likely to be key contributors to the market's growth.

Competitive Analysis

The China hemodialysis and peritoneal dialysis market is highly competitive, with several key players shaping the landscape:

Asahi Kasei Medical Co., Ltd.: A leading player in the dialysis market, Asahi Kasei Medical provides a range of innovative dialysis equipment, including hemodialysis machines and dialysis membranes, contributing to better treatment outcomes.

Shandong Weigao Group Medical Polymer Company Limited: Specializing in medical devices and dialysis consumables, Shandong Weigao plays a significant role in providing high-quality dialysis solutions in China.

Shenzhen Landwind Industry Co., Ltd.: Landwind is a key supplier of dialysis equipment and products, including peritoneal dialysis solutions and hemodialysis accessories, enhancing patient care options.

Baxter International Inc.: As a global healthcare company, Baxter offers a range of dialysis products, including peritoneal dialysis solutions and hemodialysis systems, and is a leader in providing healthcare solutions to Chinese patients.

B.Braun Melsungen AG: A major player in the dialysis market, B.Braun provides comprehensive dialysis solutions, including machines, fluids, and consumables, helping meet the growing demand for renal care in China.

Others: Other players in the market, including Fresenius Medical Care and Medtronic, continue to drive innovation and contribute to the competitive landscape, offering advanced dialysis solutions to meet the needs of Chinese patients.